Carregant...
Discrepancies in metabolomic biomarker identification from patient-derived lung cancer revealed by combined variation in data pre-treatment and imputation methods
INTRODUCTION: The identification of metabolomic biomarkers predictive of cancer patient response to therapy and of disease stage has been pursued as a “holy grail” of modern oncology, relying on the metabolic dysfunction that characterizes cancer progression. In spite of the evaluation of many candi...
Guardat en:
| Publicat a: | Metabolomics |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138701/ https://ncbi.nlm.nih.gov/pubmed/33772663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-021-01787-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|